StreetSmart Live! Presents Metallic Group of Companies on 01/26/2021. Learn More

Streetwise Reports' Article Archives — Current Month (16)

Neurosciences Firm Outlines Strategic Priorities for 2021 (01/15/2021)

ProMIS Neurosciences discusses its four priority areas in 2021.

more>

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD (01/15/2021)

Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.

more>

As Psychedelics Move Mainstream, Small Cap Positions Itself at the Center of the Industry (01/13/2021)

Two year old DELIC Corp. has gotten in on the ground floor of the nascent psychedelic sector.

more>

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues (01/13/2021)

Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%.

more>

Mesoblast Reports Phase 3 Trial Data Showing Substantial Reductions in Cardiac and Stroke Events in CHF Patients (01/11/2021)

Shares of Mesoblast Ltd. traded 36% higher after the company reported positive results from its Phase 3 DREAM-HF study showing that a single dose of rexlemestrocel-L provided very significant decreases in heart attacks, strokes and cardiac death in patients diagnosed with chronic heart failure.

more>

A Novel, First-in-Class Blood Clotting Agent Takes Shape as a Bloody Compelling Investment (01/11/2021)

Private start-up RxMP's safe way to stop bleeding inexpensively is already the envy of bigger players, states Dr. KSS, MD, PhD, editor-in-chief of PubBio.co. Can it go the distance through proof of concept?

more>

Pharma Developer Outlines 2021 Clinical Program Initiatives (01/08/2021)

Algernon Pharmaceuticals provided an update detailing its plans for 2021 clinical trials.

more>

Chimerix Expands Late-Stage Oncology Pipeline Through $78M Oncoceutics Acquisition (01/08/2021)

Chimerix Inc. shares traded 65% higher after the company reported it entered into an agreement to acquire Oncoceutics Inc. in a combination stock and cash deal valued at $78 million plus milestone incentives totaling up to $360 million.

more>

Small-Cap Tech Stock Sees Huge Rise; What's Next? (01/07/2021)

Technical analyst Clive Maund charts Leonovus and discusses what could lie ahead for the stock after it gained 150%.

more>

Biopharma's Acute Migraine Trial Yields Positive Efficacy, Safety Results (01/06/2021)

The recently announced topline results from Axsome Therapeutics' MOVEMENT study are reviewed in a Ladenburg Thalmann report.

more>

This Tiny Digital Healthcare Company's Sales Should Rocket Higher (01/06/2021)

Independent financial analyst Matt Badiali profiles a small cap whose blood glucose monitoring system works with any smartphone.

more>

Change Healthcare Shares Surge 30% on $7.8B Merger with UNH's OptumInsight (01/06/2021)

Change Healthcare shares rose to a new 52-week high after the company reported it will be combining its operations with UnitedHealth's OptumInsight in an all cash purchase transaction for $25.75 per share.

more>

This Tiny Tech Stock Is Quietly Building a Huge Business in Air Quality (01/05/2021)

Independent financial analyst Matt Badiali discusses how mCloud's technology is making it possible for office buildings to reopen during the pandemic.

more>

Biopharma Recaps 2020 Accomplishments in COVID-19, Idiopathic Pulmonary Disease (01/04/2021)

Algernon Pharmaceuticals reports that it is aggressively advancing its repurposed drug, Ifenprodil.

more>

Biopharma Appoints Adviser for Phase 3 COVID-19 Trial (01/04/2021)

Revive Therapeutics selects Dr. John Fahy, California-based pulmonary medicine expert and researcher, to join its team.

more>

Pandion Shares Get a Lift from Positive Top-Line Data in Phase 1a Autoimmune Disease Trial (01/04/2021)

Pandion Therapeutics shares traded 35% higher after the company reported positive top-line data from its Phase 1a clinical study of PT101 for treating autoimmune diseases including ulcerative colitis and systemic lupus erythematosus.

more>

More Archives

2021

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes